Loading...

Adaptive Biotechnologies Corp (NASDAQ:ADPT)

11.52 USD -0.33 USD ( -2.78% )
Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Section:
 

Relative Value

The Relative Value of one ADPT stock under the Base Case scenario is 9.87 USD. Compared to the current market price of 11.52 USD, Adaptive Biotechnologies Corp is Overvalued by 14%.

Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

ADPT Relative Value
Base Case
9.87 USD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.3
P/S
P/S
Price to Sales
10.3
Median 44
Industry 5.7
Forward Multiple 8.6
More Details
N/A
P/E
P/E
Price to Earnings
N/A
Median -
Industry 30.8
Forward Multiple -6.7
More Details
N/A
P/OCF
P/OCF
Price to OCF
N/A
Median -
Industry 27.2
Forward Multiple N/A
More Details
N/A
P/FCFE
P/FCFE
Price to FCFE
N/A
Median -
Industry 33.7
Forward Multiple N/A
More Details
3.2
P/B
P/B
Price to Book Value
3.2
Median 7.2
Industry 3.5
Forward Multiple N/A
More Details
7.9
EV/S
EV/S
Enterprise Value to Sales
7.9
Median 37.7
Industry 5.6
Forward Multiple 6.6
More Details
12
EV/GP
EV/GP
Enterprise Value to Gross Profit
12
Median 50.8
Industry 10.1
Forward Multiple N/A
More Details
N/A
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
Median -
Industry 21.6
Forward Multiple -6.7
More Details
N/A
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
Median -
Industry 26.7
Forward Multiple -5.1
More Details
N/A
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
Median -
Industry 26.8
Forward Multiple N/A
More Details
N/A
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
Median -
Industry 31.1
Forward Multiple N/A
More Details
3
EV/IC
EV/IC
Enterprise Value to IC
3
Median 10.5
Industry 3.5
Forward Multiple N/A
More Details

Multiples Across Competitors

ADPT Competitors Multiples
Adaptive Biotechnologies Corp Competitors

Country Company Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Adaptive Biotechnologies Corp
NASDAQ:ADPT
1.6B USD 10.3 N/A N/A N/A
IN
Divi's Laboratories Ltd
NSE:DIVISLAB
996B INR 11.1 33.6 24.9 27.1
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
295B HKD 24.8 75.4 73.8 73.8
CN
WuXi AppTec Co Ltd
SSE:603259
268B CNY 8.9 38 40.3 40.3
IN
Syngene International Ltd
NSE:SYNGENE
239B INR 9 60.8 31.1 52.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
234B USD 5.5 31.5 20.3 26.4

See Also

Summary
ADPT Intrinsic Value, competitors valuation, and company profile.
DCF Valuation
ADPT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADPT stock valuation using valuation multiples.
Wall Street Estimates
ADPT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADPT stock discount rate: cost of equity and WACC.
Similar Stocks
ALPHA SPREAD
Join 19,500 value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2022 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Alpha Spread Unlimited
Full access to our stock valuation platform
AAPL
Apple Inc
Price 174.03 USD
Intrinsic Value 134.5 USD
23% Overvalued
GOOGL
Alphabet Inc
Price 119.9 USD
Intrinsic Value 120.02 USD
Fairly Valued
META
Meta Platforms Inc
Price 175.24 USD
Intrinsic Value 227.15 USD
23% Undervalued
MSFT
Microsoft Corp
Price 291.54 USD
Intrinsic Value 237.34 USD
19% Overvalued
NFLX
Netflix Inc
Price 240.16 USD
Intrinsic Value 213.51 USD
11% Overvalued
SBUX
Starbucks Corp
Price 88.35 USD
Intrinsic Value 78.48 USD
11% Overvalued
Platform Features:
Platform Features:
Intrinsic Valuation
Relative Valuation
DCF Valuation
Wall St Estimates
Profitability Analysis
Solvency Analysis
Company Financials
Discount Rate Calculator
Create your account
Already have an account? Sign in
Next
Back
Create Account
OR
Sign up with Google
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.